← Back to headlines
AI Aids Pharmaceutical Companies Amid Patent Crisis
Artificial intelligence is being leveraged by pharmaceutical companies to reduce the time and cost of drug development by up to 35%, offering a solution to the ongoing patent crisis.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
